We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Evotec and Roche to Develop EVT 101 for Treatment-Resistant Depression

News   Mar 09, 2009

 
Evotec and Roche to Develop EVT 101 for Treatment-Resistant Depression
 
 
Advertisement
 

RELATED ARTICLES

Hydroxychloroquine and Lopinavir/Ritonavir Treatment Arms for COVID-19 Discontinued

News

The World Health Organization (WHO) has accepted the recommendation from the Solidarity Trial’s International Steering Committee to discontinue hydroxychloroquine and lopinavir/ritonavir study arms.

READ MORE

Next-generation Sequencing To Provide Precision Medicine for Rare Metabolic Disorders

News

Scientists have uncovered the genetic basis of aromatase deficiency – a rare metabolic disorder – using next-generation sequencing, paving the way towards precision medicine.

READ MORE

Novel Vaccine Removes Aged Immune Cells in Mice

News

In a new study, researchers from Osaka University developed a novel vaccine that removes aged immune cells and then demonstrated an improvement of diabetes-associated metabolic derangements by vaccinating obese mice.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE